TNU1368-10mg

2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)rib

2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)riboside

Ask for quotation

TNU1368-1g

2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)rib

2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)riboside

Ask for quotation

TNU1368-1mg

2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)rib

2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)riboside

Ask for quotation

MBS6119197-2g

8-Bromoguanosine (2-Amino-8-bromo-6-hydroxypurine Riboside)

759.90 €

MBS6119197-5x2g

8-Bromoguanosine (2-Amino-8-bromo-6-hydroxypurine Riboside)

2582.07 €

HY-154360

2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine

2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

Ask for quotation